Invention Grant
- Patent Title: FGF21 mutants and uses thereof
- Patent Title (中): FGF21突变体及其用途
-
Application No.: US13196544Application Date: 2011-08-02
-
Publication No.: US08410051B2Publication Date: 2013-04-02
- Inventor: Edward John Belouski , Murielle Marie Ellison , Agnes Eva Hamburger , Randy Ira Hecht , Yue-Sheng Li , Mark Leo Michaels , Jeonghoon Sun , Jing Xu
- Applicant: Edward John Belouski , Murielle Marie Ellison , Agnes Eva Hamburger , Randy Ira Hecht , Yue-Sheng Li , Mark Leo Michaels , Jeonghoon Sun , Jing Xu
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Mark K. Hehman, Esq.
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K14/50 ; C12N1/21 ; C12N5/10 ; C12N15/12 ; C12N15/63
Abstract:
The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
Public/Granted literature
- US20120003216A1 FGF21 MUTANTS AND USES THEREOF Public/Granted day:2012-01-05
Information query
IPC分类:
